Solucion InterSol

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Solucion InterSol
Generic name
SOLUCION ADITIVA PARA PLAQUETAS 3
Manufacturer
Fenwal, Inc.
Product type
HUMAN PRESCRIPTION DRUG
SPL set ID
d5eaf5f4-67d3-4475-af9a-f5b0f882f5d1
SPL ID
71e5dcd0-4aa3-4cb6-89b3-8229f73c75fc
Version
3
Effective date
2021-10-04
Source export date
2026-09-28
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:18:17
Harmonized routes table
Harmonized routes
INTRAVENOUS

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

Warnings and Precautions: • InterSol solution is NOT FOR DIRECT INTRAVENOUS INFUSION. • Do not use if particulate matter is present or if the solution is cloudy. • Do not use if the container is damaged, leaking or if there is any visible sign of deterioration. • Do not vent. • Do not reuse. Discard unused or partially used InterSol solution. • Protect from sharp objects. • Verify that the InterSol solution has been securely attached to the PAS Connector line to avoid disconnection and leaks.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

Adverse Reactions: InterSol solution is added to AMICUS-derived leukoreduced platelet concentrates after the apheresis procedure is complete. It is not for direct intravenous infusion. InterSol solution is not expected to cause adverse events other than those normally associated with platelet transfusion.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.